Cargando…
Monoclonal antibodies and Fc fragments for treating solid tumors
Advances in biotechnology, better understanding of pathophysiological processes, as well as the identification of an increasing number of molecular markers have facilitated the use of monoclonal antibodies and Fc fragments in various fields in medicine. In this context, a rapidly growing number of t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266862/ https://www.ncbi.nlm.nih.gov/pubmed/22291463 http://dx.doi.org/10.2147/BTT.S19955 |